The Cephalic Insulin Response to Meal Ingestion in Humans Is Dependent on Both Cholinergic and Noncholinergic Mechanisms and Is Important for Postprandial Glycemia
- 1 May 2001
- journal article
- Published by American Diabetes Association in Diabetes
- Vol. 50 (5) , 1030-1038
- https://doi.org/10.2337/diabetes.50.5.1030
Abstract
We studied the mechanisms and physiological relevance of the cephalic insulin response to meal ingestion in 12 healthy women (age 63 ± 0.4 years; BMI 27.7 ± 1.7 kg/m2). The ganglionic antagonist, trimethaphan, which impairs neurotransmission across parasympathetic and sympathetic autonomic ganglia, or atropine or saline was given intravenously during the first 15 min after ingestion of a standard meal (350 kcal). During saline infusion, insulin levels increased during the first 10 min after meal ingestion, whereas the first increase in glucose was evident at 15 min. The preabsorptive 10-min insulin response was reduced by 73 ± 11% by trimethaphan (P = 0.009), accompanied by impaired reduction of glucose levels from 25 to 60 min after meal ingestion (Δglucose = –1.27 ± 0.5 [with saline] vs. 0.1 ± 0.4 mmol/l [with trimethaphan]; P = 0.008). This reduction at 25–60 min in glucose levels correlated significantly to the 10-min insulin response (r = 0.65, P = 0.024). The 10-min insulin response to meal ingestion was also reduced by atropine, but only by 20 ± 9% (P = 0.045), which was lower than the reduction with trimethaphan (P = 0.004). The preabsorptive insulin response was not accompanied by any increase in circulating levels of gastric inhibitory polypeptide (GIP) or glucagon-like peptide 1 (GLP-1). In conclusion, 1) the early preabsorptive insulin response to meal ingestion in humans can be largely attributed to autonomic activation mediated by noncholinergic and cholinergic mechanisms, 2) this cephalic insulin response is required for a normal postprandial glucose tolerance, and 3) GIP and GLP-1 do not contribute to the preabsorptive cephalic phase insulin response to meal ingestion.Keywords
This publication has 53 references indexed in Scilit:
- PAC1 receptor–deficient mice display impaired insulinotropic response to glucose and reduced glucose toleranceJournal of Clinical Investigation, 2000
- The Glucagon-Like PeptidesEndocrine Reviews, 1999
- Pituitary Adenylate Cyclase-Activating Polypeptide Stimulates Insulin and Glucagon Secretion in HumansJournal of Clinical Endocrinology & Metabolism, 1997
- Activation of autonomic nerves and the adrenal medulla contributes to increased glucagon secretion during moderate insulin-induced hypoglycemia in womenDiabetes, 1997
- Rapid Oscillations in Plasma Glucagon-Like Peptide-1 (GLP-1) in Humans: Cholinergic Control of GLP-1 Secretion via Muscarinic ReceptorsJournal of Clinical Endocrinology & Metabolism, 1997
- Gastrointestinal motor and secretory responses to cholinergic stimulation in humans. Differential modulation by muscarinic and cholecystokinin receptor blockadeEuropean Journal of Clinical Investigation, 1995
- Effects of muscarinic blockade on insulin secretion and on glucose‐induced thermogenesis in lean and obese human subjectsEuropean Journal of Clinical Investigation, 1991
- Direct muscarinic cholinergic inhibition of hepatic glucose production in humans.Journal of Clinical Investigation, 1988
- Loss of early phase of insulin release in humans impairs glucose tolerance and blunts thermic effect of glucoseDiabetes, 1987
- Meal-induced increases in parasympathetic and sympathetic activity elicit simultaneous rises in plasma insulin and free fatty acidsPhysiology & Behavior, 1986